Non-seminomatous Germ Cell Tumor
📧 Sign up to get email alerts when something new happens for Non-seminomatous Germ Cell Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors [Phase 1]
A Phase 1 trial is evaluating adding Pedmark (sodium thiosulfate) to cisplatin chemotherapy to reduce cisplatin-induced hearing loss in men …
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Phase II Trial of Cabozantinib With Patients With Refractory GCTs [Phase 2]
Update on a Phase II trial of cabozantinib in patients with refractory germ cell tumors.
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors [NA]
ClinicalTrials.gov reports an ongoing study validating a treatment algorithm for poor-risk non-seminomatous germ cell tumors. The status is …
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT [Phase 2]
A Phase 2 trial is evaluating maintenance oral etoposide after high-dose chemotherapy for germ cell tumors. The study compares maintenance t…
-
CLINICAL_TRIALS research · 2020-07-09Clinical Trial Update: Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy [Phase 2]
A Phase 2 imaging-focused trial evaluating how imaging of integrins αvβ3 relates to characterizing residual masses in non-seminomatous germ …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2006-09-08Clinical Trial Update: Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors [Phase 2]
Phase 2 clinical trial evaluating a combination of gemcitabine, cisplatin, and ifosfamide in patients with relapsed non-seminomatous germ ce…